| # | Drug | Count |
|---|---|---|
| 0 | ETANERCEPT | 208 |
| 1 | ACETAMINOPHEN | 207 |
| 2 | METHOTREXATE SODIUM | 206 |
| 3 | METHYLPREDNISOLONE | 192 |
| 4 | ACETAMINOPHEN 500MG | 191 |
| 5 | ACETAMINOPHEN TABLET EXTENDED RELEASE | 191 |
| 6 | PAIN RELIEVER | 191 |
| 7 | PREDNISONE | 177 |
| 8 | METHOTREXATE | 170 |
| 9 | LANSOPRAZOLE | 165 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | HYDROCORTISONE VALERATE | 27 | 0.0430 |
| 1 | VANCOMYCIN HYDROCHLORIDE | 78 | 0.0093 |
| 2 | TETRAHYDROZOLINE HYDROCHLORIDE | 2 | 0.0068 |
| 3 | TECLISTAMAB-CQYV | 13 | 0.0055 |
| 4 | FERROUS ASPARTO GLYCINATE, IRON, ASCORBIC ACID, FOLIC ACID, CYANOCOBALAMIN, ZINC, AND SUCCINIC ACID | 3 | 0.0049 |
| 5 | CEFTAROLINE FOSAMIL | 4 | 0.0048 |
| 6 | BUPRENORPHINE HCL | 4 | 0.0046 |
| 7 | ANIDULAFUNGIN | 7 | 0.0043 |
| 8 | PRAZOSIN | 24 | 0.0038 |
| 9 | METHYLPREDNISOLONE ACETATE | 30 | 0.0037 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 524 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 368 |
| 2 | Tumor Necrosis Factor Blocker [EPC] | 325 |
| 3 | Proton Pump Inhibitor [EPC] | 223 |
| 4 | CD20-directed Cytolytic Antibody [EPC] | 185 |
| 5 | Folate Analog Metabolic Inhibitor [EPC] | 180 |
| 6 | beta-Adrenergic Blocker [EPC] | 146 |
| 7 | Vitamin C [EPC] | 145 |
| 8 | Platelet Aggregation Inhibitor [EPC] | 137 |
| 9 | Benzodiazepine [EPC] | 121 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD38-directed Cytolytic Antibody [EPC] | 50 | 0.0085 |
| 1 | Lipopeptide Antibacterial [EPC] | 26 | 0.0027 |
| 2 | Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC] | 4 | 0.0022 |
| 3 | Bispecific CD20-directed CD3 T Cell Engager [EPC] | 7 | 0.0017 |
| 4 | Vitamin D2 Analog [EPC] | 10 | 0.0014 |
| 5 | GLP-2 Analog [EPC] | 18 | 0.0013 |
| 6 | Histamine-1 Receptor Antagonist [EPC] | 113 | 0.0013 |
| 7 | Lipid-based Polyene Antifungal [EPC] | 17 | 0.0013 |
| 8 | CD19-directed Cytolytic Antibody [EPC] | 1 | 0.0012 |
| 9 | Rifamycin Antimycobacterial [EPC] | 4 | 0.0011 |